Effects of ZOL treatment on pulmonary metastases.

Slides:



Advertisements
Similar presentations
Volume 24, Issue 5, Pages (November 2013)
Advertisements

18F-FDG uptake is a noninvasive biomarker of combined MEK–mTORC1 inhibition. 18F-FDG uptake is a noninvasive biomarker of combined MEK–mTORC1 inhibition.
25(OH)D and 1,25(OH)2D perfusion treatment effect on cancer-related markers: IF stains illustrating expression levels for Ki-67 (A), cyclin D1 (B), ErbB-2.
Combined PLX3397 and PTX treatment inhibits metastasis in a CD8-dependent manner. Combined PLX3397 and PTX treatment inhibits metastasis in a CD8-dependent.
Effects of AG-221 treatment on survival and cell differentiation in an IDH2R140Q primary human AML xenograft model. Effects of AG-221 treatment on survival.
Effects of SC144 on in vivo ovarian tumor.
BV6 increases tumor burden in bone.
Validation of St6GalNAc2 as a metastasis suppressor gene.
Gr-1+ MDSC in tumor-bearing mice produce IL-6.
Volume 25, Issue 13, Pages e2 (December 2018)
Effect of antiangiogenic TKIs and rMVA–CEA–TRICOM vaccine on tumor compactness, tight junctions, and intratumoral pressure in the MC38-CEA model. Effect.
Anti-CD20 CAR exPBNK significantly inhibit growth of Raji cells in xenografted mice. Anti-CD20 CAR exPBNK significantly inhibit growth of Raji cells in.
mpJX-594 effects on tumor burden and leukocyte influx.
Effect of MI-773 and/or cisplatin in a preclinical model of ACC
Effect of MI-773 dosing on long-term efficacy.
BCX suppresses lung tumor, α7-nAChR expression, and α7-nAChR signaling in the NNK-treated mice. BCX suppresses lung tumor, α7-nAChR expression, and α7-nAChR.
Expression of p110γ isoform in macrophages promotes tumor growth and angiogenesis. Expression of p110γ isoform in macrophages promotes tumor growth and.
Vaccine MN confer protective innate and adaptive immunity.
Sildenafil protects the intestinal epithelium from DSS-induced damage.
CO-1686 does not inhibit WT EGFR signaling in vivo and is active in EGFR-mutant transgenic mouse lung cancer models. CO-1686 does not inhibit WT EGFR signaling.
Effect of mitomycin C and bortezomib on the growth of LS174T intraperitoneal tumors. Effect of mitomycin C and bortezomib on the growth of LS174T intraperitoneal.
Effects of PS-341 on apoptosis in orthotopic human pancreatic tumors.
Effects of AG on the colon histology score in the acute DSS colitis model. Effects of AG on the colon histology score in the acute DSS colitis model. Ten.
SDF-1/CXCR4 axis is involved in CD133+ tumor cell metastasis toward a lymphatic metastasis niche. SDF-1/CXCR4 axis is involved in CD133+ tumor cell metastasis.
Effects of DPM treatment on tumor volume, tumor mass, and pulmonary metastasis at experimental end point. Effects of DPM treatment on tumor volume, tumor.
In vivo growth-inhibitory effect of perifosine on bevacizumab-resistant CCC. A, the effect of bevacizumab (BEV) on CCC growth in vivo. In vivo growth-inhibitory.
Accelerated metastasis spread in tumor-bearing mice treated with paclitaxel and anakinra. Accelerated metastasis spread in tumor-bearing mice treated with.
Anti-Flk-1 treatment inhibits growth of s. c. 4T1 and B16 tumors. s. c
Rapamycin decreases PD-L1 expression in lung tumors in vivo.
A, TSG-6 staining in TRAMP tissue and TRAMP cell lines.
Anti-Flk-1 mAb treatment reduces vessel density in tumors.
Overexpression of DDB2 reduces invasive abilities in lungs of aggressive breast tumor cells. Overexpression of DDB2 reduces invasive abilities in lungs.
Anti-Flk-1 mAb inhibits vascularization of Matrigel plugs.
PVHA increased anti-PD-L1–mediated growth inhibition in 4T1/HAS3 tumors. PVHA increased anti-PD-L1–mediated growth inhibition in 4T1/HAS3 tumors. A, 4T1/HAS3.
Tipifarnib combined with bortezomib induces cell death in diverse multiple myeloma and AML cell lines. Tipifarnib combined with bortezomib induces cell.
Influenza vaccine enhances NK cell function through IFN-α.
SY-1425 induces maturation in RARA-high AML
Impairment of liver function upon treatment with 4D5MOCB-ETA.
Example inverse FF-OCT images (left column) and corresponding histology images (right column) of ovarian metastases. Example inverse FF-OCT images (left.
NT157 treatment inhibits LNCaP xenograft growth and delays castration-resistant progression. NT157 treatment inhibits LNCaP xenograft growth and delays.
Tumor cell clusters with increased tumorigenesis, metastasis, and CD44 expression. Tumor cell clusters with increased tumorigenesis, metastasis, and CD44.
HMQ1611 inhibited breast tumor growth in mice.
Fig. 6 Antitumor effect on tumor growth and pulmonary metastasis of CSSD-9 in vivo. Antitumor effect on tumor growth and pulmonary metastasis of CSSD-9.
Dasatinib overcomes the growth and metastatic spread of vemurafenib-resistant tumors. Dasatinib overcomes the growth and metastatic spread of vemurafenib-resistant.
A, percentage of mitotic and multinucleated HeLa MR cells at each time point. A, percentage of mitotic and multinucleated HeLa MR cells at each time point.
Effect of CDV on human SF7796 xenografts in vivo.
Impact of eNOS expression and treatment with GSNO on prostate tumor growth. Impact of eNOS expression and treatment with GSNO on prostate tumor growth.
Effect of dietary feeding of silibinin on DU145 tumor xenograft growth in athymic male nude mice. Effect of dietary feeding of silibinin on DU145 tumor.
A, effect of Z-VAD treatment on synchronized HeLa MR cells.
Comparison of in vivo activity of 4D5scFvZZ and 4D5scFv.
Mean body weights (grams) of athymic female mice implanted with MDA-MB-231 breast carcinoma xenografts. Mean body weights (grams) of athymic female mice.
RhuαVEGF and rhuαVEGF/paclitaxel mediated growth inhibition in an androgen-independent prostate cancer xenograft model. rhuαVEGF and rhuαVEGF/paclitaxel.
Increased expression of angiogenic factors and inflammatory cytokines in mice exposed to hypoxia. Increased expression of angiogenic factors and inflammatory.
MGA271 exhibits potent in vivo antitumor activity toward tumor cell carcinoma xenografts. MGA271 exhibits potent in vivo antitumor activity toward tumor.
In vivo effects of TTFields on intradermal tumors in mice.
TAE-684 effectively inhibits the growth of H3122 in vivo.
Effect of MZ treatment on lung colony formation in an experimental metastasis. Effect of MZ treatment on lung colony formation in an experimental metastasis.
Proliferation of TA3-Ha and TA3-St cells in vitro and in vivo.
PDL192 and inhibit the growth of xenograft tumors.
Treatment with a Ron inhibitor significantly reduces metastatic outgrowth. Treatment with a Ron inhibitor significantly reduces metastatic outgrowth. A,
Inhibition of spontaneous pulmonary metastasis and prolonged survival after removal of primary tumor and intratracheal delivery of rAAV2/5-VAS. Inhibition.
W. chinensis extract attenuates tumor growth of 103E (a subline of CWR22Rv1) engrafted in the prostate of nude mice. W. chinensis extract attenuates tumor.
GCS-100 selectively kills KRAS-addicted lung tumors.
Transgenic mice with constitutively active NIK show increased tumor growth in bone. Transgenic mice with constitutively active NIK show increased tumor.
BV6 increases bone metastasis.
Recruitment of CD8+, CD4+, and Foxp3+ cells into oral lesions in response to anti–PD-1 treatment. Recruitment of CD8+, CD4+, and Foxp3+ cells into oral.
In vivo shRNA screening strategy.
TAMs upregulate DNMT1 in gastric cancer cells through the CCL5/CCR5/STAT3 pathway. TAMs upregulate DNMT1 in gastric cancer cells through the CCL5/CCR5/STAT3.
AXL knockout does not prevent dormancy.
PD and efficacy of AZD4785 in a KRAS wild-type lung cancer PDX model
Presentation transcript:

Effects of ZOL treatment on pulmonary metastases. Effects of ZOL treatment on pulmonary metastases. A, on sacrifice, the lungs were removed for BLI and quantification of tumor burden. Photos depict the signal emitted from individual lungs in each group of mice. B, the graph represents BLI measurements, which are expressed as the sum of integrated photon counts per second. Columns, mean; bars, SE. *, P < 0.01. C, 20 animals were inoculated with untagged parental K-HOS cells and animals were then assigned randomly into two groups: (left) the control untreated group and (right) the ZOL weekly treated group (100 μg/kg dose once weekly). Tibial tumor area was calculated from representative histologic sections and expressed as an average tumor area per group (mm2). Tibial tumor volume (mm3) was also measured using μCT software, as described in Materials and Methods. Despite the protective effects of ZOL on OS-induced bone destruction, ZOL had no effect on tibial tumor burden. Photographs are representative of H&E-stained sections of mouse lungs at 35 d after inoculation with K-HOS cells from vehicle- or ZOL-treated animals. Histologic sections of the lungs were photographed and used to measure tumor area and total lung area. D, graph represents the tumor burden in the lung expressed as percentage of total lung. Data shown in each case are an average from a representative section of each animal. Columns, mean; bars, SE. *, P < 0.05. Agatha Labrinidis et al. Clin Cancer Res 2009;15:3451-3461 ©2009 by American Association for Cancer Research